E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers G > Headlines for GSK Consumer Healthcare Capital US LLC > News item
Published on 3/2/2023 in the Prospect News Investment Grade Daily and Prospect News Liability Management Daily.

Haleon’s GSK calls $300 million floating-rate notes due 2024

Chicago, March 2 – Haleon plc’s wholly owned subsidiary GSK Consumer Healthcare Capital US LLC called its $300 million outstanding floating-rate senior notes due 2024 (Cusips: 36264FAJ0, 36264GAB5, U0396GAB9) for redemption, according to a press release.

The notes will be redeemed on March 24 at par plus accrued interest.

Deutsche Bank Trust Co. Americas is the paying agent.

Haleon was separated from GlaxoSmithKline plc in 2022. The headquarters are in Brentford, United Kingdom.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.